CATALYST PHARMACEUTICALS INC (CPRX) Stock Balance Sheet
NASDAQ:CPRX - Nasdaq - US14888U1016 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 580.66M | 517.55M | 137.64M | 298.40M | 171.40M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 19.80M | |||
| Receivables | 72.24M | 65.48M | 53.51M | 10.40M | 6.60M | |||
| Inventories | 19.78M | 19.54M | 15.64M | 6.80M | 7.90M | |||
| Other Current Assets | 13.05M | 21.04M | 12.54M | 5.20M | 4.30M | |||
| Total Current Assets | 685.72M | 623.61M | 219.33M | 320.80M | 210.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.40M | 3.58M | 3.70M | 3.60M | 4.00M | |||
| Investments And Advances | 24.21M | 21.56M | 16.49M | N/A | N/A | |||
| Intangibles | 147.33M | 156.67M | 194.05M | 32.50M | N/A | |||
| Other Non-Current Assets | 48.22M | 45.98M | 36.54M | 18.70M | 23.70M | |||
| Total Non-Current Assets | 223.15M | 227.80M | 250.78M | 54.80M | 27.70M | |||
| TOTAL ASSETS | 908.87M | 851.41M | 470.11M | 375.60M | 237.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 84.64M | 99.19M | 47.53M | 31.50M | 24.00M | |||
| Accounts Payable | 11.20M | 16.59M | 14.79M | 4.00M | 2.80M | |||
| Other Current Liabilities | 15.81M | 4.89M | 13.73M | 22.10M | 300.00K | |||
| Total Current Liabilities | 111.65M | 120.68M | 76.06M | 57.60M | 27.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.94M | 3.10M | 6.17M | 17.60M | 3.90M | |||
| Total Non-Current Liabilities | 2.94M | 3.10M | 6.17M | 17.60M | 3.90M | |||
| TOTAL LIABILITIES | 114.59M | 123.78M | 82.23M | 75.20M | 31.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 341.90M | 285.16M | 121.27M | 49.90M | -26.30M | |||
| Additional Paid In Capital | 452.28M | 442.29M | 266.49M | 250.40M | 233.20M | |||
| Common Shares | 122.00K | 121.00K | 107.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -17.00K | 64.00K | 14.00K | 0.00 | -100.00K | |||
| Shares Outstanding | 121.96M | 120.88M | 107.12M | 105.30M | 103.00M | |||
| Tangible Book Value per Share | 5.30 | 4.72 | 1.81 | 2.54 | 2.01 | |||
| Total Shareholders' Equity | 794.28M | 727.63M | 387.88M | 300.40M | 206.80M | |||
| TOTAL LIABILITIES AND EQUITY | 908.87M | 851.41M | 470.11M | 375.60M | 237.80M | |||
| Statistics | ||||||||
| Current Ratio | 6.14 | 5.17 | 2.88 | 5.57 | 7.75 | |||
| Return On Assets (ROA) | 21.71% | 19.25% | 15.19% | 22.12% | 16.61% | |||
| Return On Equity (ROE) | 24.85% | 22.52% | 18.41% | 27.66% | 19.10% | |||
| Return On Invested Capital (ROIC) | 21.96% | 20.21% | 16.67% | 24.22% | 18.82% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 80.84% | 69.26% | 25.62% | 393.02% | 203.34% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 252.85% | 261.29% | 105.33% | N/A | 203.34% | |||
All data in USD , ROIC based on taxRate of 0.24